Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2025

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following tables set forth the computation of basic and diluted net loss per share of Common Stock, Series A Preferred Stock, and Series B Preferred Stock (in thousands, except share and per share amounts):

	Three Months Ended June 30,
	2025									2024 (Revised)
	Series A Preferred Stock			Series B Preferred Stock			Common Stock			Series A Preferred Stock			Series B Preferred Stock			Common Stock
Numerator:
Allocated net loss	$	(8,999	)	$	(3,653	)	$	(60,877	)	$	(8,041	)	$	(8,043	)	$	(42,866	)
Denominator:
Weighted average shares outstanding, basic and diluted		67,686			6,868			114,466,080			74,465			18,621			99,240,030
Net loss per share, basic and diluted	$	(132.95	)	$	(531.89	)	$	(0.53	)	$	(107.98	)	$	(431.93	)	$	(0.43	)

	Six Months Ended June 30,
	2025									2024 (Revised)
	Series A Preferred Stock			Series B Preferred Stock			Common Stock			Series A Preferred Stock			Series B Preferred Stock			Common Stock
Numerator:
Allocated net loss	$	(17,834	)	$	(7,227	)	$	(120,454	)	$	(17,025	)	$	(11,546	)	$	(88,727	)
Denominator:
Weighted average shares outstanding, basic and diluted		67,788			6,868			114,463,810			74,465			12,626			97,022,345
Net loss per share, basic and diluted	$	(263.08	)	$	(1,052.27	)	$	(1.05	)	$	(228.63	)	$	(914.46	)	$	(0.91	)

Summary of Potential Dilutive Securities

The Company’s potential dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive and would result in a reduction to net loss per share. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated above because including them would have had an anti-dilutive effect:

	June 30,
	2025		2024
Stock options to purchase common stock		27,107,864		20,836,714
Performance-based restricted stock units subject to vesting		3,054,000		2,714,000
Time-based restricted stock units subject to vesting		80,000		80,000
		30,241,864		23,630,714